Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The obesity segment held the largest market share in 2025
Interestingly, only the CoQ10 plus vitamin E treatment significantly reduced low-density lipoprotein cholesterol (LDL-C), increased high-density lipoprotein cholesterol (HDL-C), reduced atherogenic coefficient, and decreased visceral adiposity index values
Domestic shipping: EU UK USA AU 57 days International shipping: 714 days 4 publications found Last 10 years 3 most recent shown Source: PubMed / NCBI Last 10 years Refreshed every 24 hours For research reference only not clinical guidance
It is not a drug, supplement, or food product
A healthy diet may help the body make and maintain glutathione
REDEFINE 2 Trial Type 2 Diabetes with Obesity The companion REDEFINE 2 trial, also published in 2025, enrolled 1,206 adults with type 2 diabetes and obesity or overweight, demonstrating the combinations efficacy in this more metabolically compromised population: Mean weight loss of 13.7% compared to 3.4% with placebo over 68 weeks 73.5% achieved hemoglobin A1c of 6.5% or less compared to 15.9% with placebo Greater proportions reaching multiple weight thresholds including 5%, 10%, 15%, and 20% reduction Significant glycemic improvement with mean A1c reduction demonstrating disease modification potential Favorable metabolic profile changes including improvements in blood pressure and lipids These findings established that the combination maintains substantial efficacy even in patients with the metabolic dysfunction of established type 2 diabetes, a population often showing reduced response to weight-loss interventions
US$ 28.73
US$ 25.07
US$ 26.61
US$ 25.24
